Bayhill Therapeutics Names Robert S. King Vice President of Manufacturing.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Bayhill Therapeutics Inc., a clinical stage biotechnology company developing innovative therapies for autoimmune diseases Autoimmune diseases A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs. Mentioned in: Complement Deficiencies, Premature Menopause , has named Robert S. King, Ph.D. Vice President of Manufacturing. Dr. King will report to CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Mark Schwartz and will be responsible for all manufacturing activities as the company moves its product candidates through clinical trials toward commercialization. Dr. King brings more than 18 years of biotechnology industry experience to Bayhill. He most recently was the Vice President of Product Development and Manufacturing at Rinat Neuroscience Corp., a division of Pfizer Global Research and Development, where he was responsible for technical development of all product candidates. Previously, Dr. King was responsible for process development, formulations and manufacturing of all compounds in clinical development at Millennium Pharmaceuticals in South San Francisco South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. and COR Therapeutics, where he oversaw product development of INTEGRILIN(TM) injection from proof of concept to commercialization. He also served in various product development roles at Scios Inc., formerly California Biotechnology Inc., and Molecular Devices Corp. Dr. King holds several patents related to manufacturing processes and his work has been published in numerous scientific journals. He holds a Ph.D. in Chemical Engineering from the University of California, Berkeley The University of California, Berkeley is a public research university located in Berkeley, California, United States. Commonly referred to as UC Berkeley, Berkeley and Cal and a Bachelor of Science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies degree in Chemical Engineering from the University of Washington. "We are extremely pleased to have Robert join Bayhill Therapeutics' senior management team," Dr. Schwartz said. "Robert's breadth of manufacturing experience, including successfully moving product candidates through clinical trials to commercialization, will be invaluable to Bayhill as its antigen-specific DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. vaccines for multiple sclerosis and autoimmune diabetes progress through Phase II trials and potentially to market." "Bayhill has made significant progress in moving its technology through clinical development," Dr. King commented. "I look forward to joining Bayhill's excellent management team in order to support the late-stage development and commercialization efforts of the company's exciting products." About Bayhill Therapeutics Bayhill Therapeutics Inc. is a clinical-stage biotechnology company focused on developing and commercializing therapeutics that fundamentally alter the way autoimmune diseases are treated. The company has developed two therapeutic platforms with broad applicability to a range of autoimmune diseases. Bayhill's BHT-DNA autoimmune vaccine is designed to eliminate disease-causing cells without affecting normal protective immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. cells. BHT-DNA is being studied in a Phase II trial for multiple sclerosis and a Phase I/II trial for autoimmune diabetes. Bayhill's second therapeutic is an oligonucleotide in preclinical development for systemic lupus erythematosus Systemic Lupus Erythematosus Definition Systemic lupus erythematosus (also called lupus or SLE) is a disease where a person's immune system attacks and injures the body's own organs and tissues. Almost every system of the body can be affected by SLE. . More information about Bayhill Therapeutics is available at www.bayhilltherapeutics.com. |
|
|||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion